Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BM722S - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#BM722S, RRID:AB_1007854
- Product name
- anti Tenascin / TNC / HXB
- Antibody type
- Monoclonal
- Antigen
- Protein preparation from a homogenate of a Human mammary tumour specimen.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- T2H5
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
Submitted references Immunohistochemical localization of collagen type III and type IV, laminin, tenascin and alpha-smooth muscle actin (alphaSMA) in the human liver in peliosis.
Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Gulubova M
Pathology, research and practice 2002;198(12):803-12
Pathology, research and practice 2002;198(12):803-12
Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM, van Garderen E, Schalken JA, Nederbragt H
Journal of comparative pathology 2002 Jan;126(1):1-8
Journal of comparative pathology 2002 Jan;126(1):1-8
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ, Pavlidis N
European journal of cancer (Oxford, England : 1990) 2002 Dec;38(18):2362-70
European journal of cancer (Oxford, England : 1990) 2002 Dec;38(18):2362-70
Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Tökés AM, Hortoványi E, Csordás G, Kulka J, Mózes G, Hatalyák A, Kádár A
Anticancer research 1999 Jan-Feb;19(1A):175-9
Anticancer research 1999 Jan-Feb;19(1A):175-9
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunohistochemistry staining of tonsil (paraffin-embedded sections) with anti-Human Tenascin antibody (T2H5) Cat.-No BM722S.